Metabolite mimicry identifies butyrate analogs with select protective functions in the intestinal mucosa
Open Access
- 9 April 2026
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (15)
Abstract
Microbial-derived short-chain fatty acids regulate a variety of pathways in the healthy colonic mucosa. In particular, butyrate serves as the primary energy source for colonocytes and regulates gene transcription by stabilizing the transcription factor hypoxia-inducible-factors (HIF) and functioning as a histone deacetylase (HDAC) inhibitor. A limitation of butyrate as a therapeutic is its rapid metabolism in differentiated colonocytes. Furthermore, intestinal stem cells (ISCs) respond differently to butyrate, preferentially using glucose for energy procurement. To address these limitations, we explored metabolite mimicry to identify compounds with potent or selective biological responses within the butyrate pathway(s). We found an analog, 3-chlorobutyrate (3-Cl BA), that significantly enhances epithelial barrier formation and wound healing in vitro. Mechanistically, we revealed that 3-Cl BA is a potent HDAC inhibitor. Furthermore, unlike butyrate, 3-Cl BA does not stabilize HIF and it is not used as metabolic fuel. In vivo studies in a dextran sulfate sodium-colitis model revealed that contrary to butyrate, 3-Cl BA is protective. Studies in stem-like colonoids demonstrated that only butyrate inhibits ISC proliferation and differentiation. Furthermore, it was recently reported that HIF stabilization inhibits ISCs activity. Given the fact that butyrate but not 3-Cl BA stabilizes HIF, we surmised that 3-Cl BA would circumvent these detrimental functional consequences. We demonstrate here that pharmacologic HIF stabilization inhibits colonoid differentiation and that genetic loss of HIF significantly promotes ISC differentiation. This study reveals a promising butyrate analog protective in colitis and demonstrates the advantages of metabolite mimicry to dissect selective biological functions from major metabolites in the gut.Keywords
All Related Versions
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK50189)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK95491)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK104713)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK143211)
- U.S. Department of Veterans Affairs (BX002182)
- U.S. Department of Veterans Affairs (BX006475)
- U.S. Department of Veterans Affairs (IK2BX006088)
- Crohn's and Colitis Foundation (929250)
- Crohn's and Colitis Foundation (831495)
- National Institute of Allergy and Infectious Diseases (DP2AI184728)
- National Institute of General Medical Sciences (T34GM149812)
- National Institute of General Medical Sciences (T32GM149361)
This publication has 67 references indexed in Scilit:
- Butyrate’s role in human health and the current progress towards its clinical application to treat gastrointestinal diseaseClinical Nutrition, 2022
- Human microbial metabolite mimicry as a strategy to expand the chemical space of potential drugsDrug Discovery Today, 2020
- Butyrate Protects Mice from Clostridium difficile-Induced Colitis through an HIF-1-Dependent MechanismCell Reports, 2019
- Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular HealthCurrent Nutrition Reports, 2018
- Microbiota and metabolic diseasesEndocrine, 2018
- The Colonic Crypt Protects Stem Cells from Microbiota-Derived MetabolitesCell, 2016
- Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier FunctionCell Host & Microbe, 2015
- Chromatin modifying agents – the cutting edge of anticancer therapyDrug Discovery Today, 2011
- Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functionsBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistryThe Journal of Pathology, 1994